nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.056	0.0712	CbGpPWpGaD
Mepivacaine—SCN9A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0453	0.0576	CbGpPWpGaD
Mepivacaine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0433	0.0551	CbGpPWpGaD
Mepivacaine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0416	0.0529	CbGpPWpGaD
Mepivacaine—SCN4A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0416	0.0529	CbGpPWpGaD
Mepivacaine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0401	0.051	CbGpPWpGaD
Mepivacaine—SCN10A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0401	0.051	CbGpPWpGaD
Mepivacaine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0282	0.0359	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0215	0.0273	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0174	0.0221	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0166	0.0211	CbGpPWpGaD
Mepivacaine—SCN9A—pituitary gland—polycystic ovary syndrome	0.0165	0.0775	CbGeAlD
Mepivacaine—SCN9A—adipose tissue—polycystic ovary syndrome	0.0165	0.0772	CbGeAlD
Mepivacaine—SCN2A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.016	0.0203	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.016	0.0203	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0154	0.0196	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0154	0.0196	CbGpPWpGaD
Mepivacaine—SCN9A—adrenal gland—polycystic ovary syndrome	0.0148	0.0692	CbGeAlD
Mepivacaine—SCN4A—pituitary gland—polycystic ovary syndrome	0.0148	0.0691	CbGeAlD
Mepivacaine—SCN4A—adipose tissue—polycystic ovary syndrome	0.0147	0.0688	CbGeAlD
Mepivacaine—SCN8A—endocrine gland—polycystic ovary syndrome	0.0146	0.0683	CbGeAlD
Mepivacaine—SCN4A—adrenal gland—polycystic ovary syndrome	0.0132	0.0617	CbGeAlD
Mepivacaine—SCN2A—pituitary gland—polycystic ovary syndrome	0.0131	0.0612	CbGeAlD
Mepivacaine—SCN10A—pituitary gland—polycystic ovary syndrome	0.0126	0.059	CbGeAlD
Mepivacaine—SCN3A—pituitary gland—polycystic ovary syndrome	0.0115	0.0538	CbGeAlD
Mepivacaine—SCN3A—adipose tissue—polycystic ovary syndrome	0.0114	0.0535	CbGeAlD
Mepivacaine—SCN5A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0108	0.0138	CbGpPWpGaD
Mepivacaine—SCN2A—vagina—polycystic ovary syndrome	0.0108	0.0506	CbGeAlD
Mepivacaine—SCN3A—adrenal gland—polycystic ovary syndrome	0.0103	0.048	CbGeAlD
Mepivacaine—SCN2A—endocrine gland—polycystic ovary syndrome	0.0101	0.0474	CbGeAlD
Mepivacaine—SCN10A—endocrine gland—polycystic ovary syndrome	0.00975	0.0457	CbGeAlD
Mepivacaine—SCN3A—vagina—polycystic ovary syndrome	0.0095	0.0445	CbGeAlD
Mepivacaine—SCN5A—vagina—polycystic ovary syndrome	0.00947	0.0444	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00849	0.0108	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00812	0.0103	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00711	0.00904	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00686	0.00873	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00657	0.00835	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00657	0.00835	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00631	0.00802	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00631	0.00802	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00628	0.00799	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00608	0.00773	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00608	0.00773	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00604	0.00767	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00604	0.00767	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00582	0.0074	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00582	0.0074	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0058	0.00737	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00575	0.00731	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0055	0.00699	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00528	0.00672	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00528	0.00672	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00509	0.00648	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00509	0.00648	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—NRG1—polycystic ovary syndrome	0.00506	0.00643	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00469	0.00596	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00448	0.0057	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.0044	0.00559	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00431	0.00548	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00431	0.00548	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00428	0.00544	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00415	0.00528	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00415	0.00528	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00409	0.0052	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—INS—polycystic ovary syndrome	0.00362	0.0046	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00358	0.00455	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—polycystic ovary syndrome	0.0035	0.00445	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—DLG4—polycystic ovary syndrome	0.00321	0.00408	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00292	0.00371	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00279	0.00355	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—DLG4—polycystic ovary syndrome	0.00259	0.0033	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00249	0.00316	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—DLG4—polycystic ovary syndrome	0.00248	0.00315	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—DLG4—polycystic ovary syndrome	0.00238	0.00303	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—DLG4—polycystic ovary syndrome	0.00238	0.00303	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—DLG4—polycystic ovary syndrome	0.0023	0.00292	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—DLG4—polycystic ovary syndrome	0.0023	0.00292	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00229	0.00291	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00227	0.00289	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00214	0.00273	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00201	0.00256	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00185	0.00235	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00184	0.00234	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00177	0.00225	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00176	0.00223	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00173	0.00221	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00171	0.00218	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—DLG4—polycystic ovary syndrome	0.0017	0.00216	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—DLG4—polycystic ovary syndrome	0.0017	0.00216	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00169	0.00215	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00169	0.00215	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00166	0.00211	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00164	0.00209	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00164	0.00209	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00163	0.00207	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00163	0.00207	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—DLG4—polycystic ovary syndrome	0.00162	0.00205	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00159	0.00203	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00159	0.00203	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00154	0.00195	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00154	0.00195	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—LEP—polycystic ovary syndrome	0.00141	0.00179	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00139	0.00176	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00133	0.00169	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00127	0.00162	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00127	0.00162	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00123	0.00156	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00123	0.00156	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00123	0.00156	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—INS—polycystic ovary syndrome	0.00121	0.00153	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00116	0.00148	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00115	0.00147	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00114	0.00145	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LEP—polycystic ovary syndrome	0.00114	0.00145	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LEP—polycystic ovary syndrome	0.00109	0.00139	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00108	0.00137	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00107	0.00136	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LEP—polycystic ovary syndrome	0.00105	0.00133	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LEP—polycystic ovary syndrome	0.00105	0.00133	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.00101	0.00129	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.00101	0.00129	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000994	0.00126	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000975	0.00124	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000965	0.00123	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000951	0.00121	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000942	0.0012	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.000932	0.00119	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000913	0.00116	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000913	0.00116	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000901	0.00115	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—INS—polycystic ovary syndrome	0.000896	0.00114	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.000896	0.00114	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000881	0.00112	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000881	0.00112	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000866	0.0011	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000866	0.0011	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000864	0.0011	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.000864	0.0011	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000864	0.0011	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000863	0.0011	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000835	0.00106	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000835	0.00106	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000825	0.00105	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000793	0.00101	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000793	0.00101	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000765	0.000972	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000765	0.000972	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000761	0.000968	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—polycystic ovary syndrome	0.000738	0.000938	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000711	0.000904	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000667	0.000848	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000619	0.000787	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000616	0.000783	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000607	0.000772	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000597	0.000759	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000589	0.000749	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000587	0.000746	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.000571	0.000726	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000566	0.000719	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000566	0.000719	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000548	0.000697	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.000548	0.000697	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000546	0.000694	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000546	0.000694	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000538	0.000683	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000529	0.000672	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.000529	0.000672	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	0.000527	0.00067	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000426	0.000541	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000407	0.000518	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000391	0.000498	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.000391	0.000498	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000384	0.000488	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000377	0.00048	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000377	0.00048	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000372	0.000473	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000265	0.000337	CbGpPWpGaD
